Insider Buy/Sell Details for the Healthcare Sector — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1861)
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
753
Price
$527.47
Total Value
$397.18K
Shares Held After
52,719
% of Holdings
1.4%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
1,814
Price
$198.65
Total Value
$360.36K
Shares Held After
259,255
% of Holdings
0.7%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
956
Price
$197.84
Total Value
$189.14K
Shares Held After
261,069
% of Holdings
0.4%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
300
Price
$196.27
Total Value
$58.88K
Shares Held After
262,025
% of Holdings
0.1%
Heartflow, Inc. (HTFL)
Farquhar John C.M. — Director
Shares
9,725
Price
$25.00
Total Value
$243.12K
Shares Held After
571,725
% of Holdings
1.7%
COLLEGIUM PHARMACEUTICAL, INC (COLL)
Dieter David — EVP & General Counsel
Shares
13,976
Price
$34.92
Total Value
$488.10K
Shares Held After
77,071
% of Holdings
15.4%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
6,499
Price
$18.84
Total Value
$122.41K
Shares Held After
339,392
% of Holdings
1.9%
VIEMED HEALTHCARE, INC. (VMD)
Moore Michael — President
Shares
31,570
Price
$9.42
Total Value
$297.39K
Shares Held After
1,691,044
% of Holdings
1.8%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
2,877
Price
$24.97
Total Value
$71.84K
Shares Held After
147,053
% of Holdings
1.9%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
304
Price
$119.08
Total Value
$36.20K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,730
Price
$118.37
Total Value
$204.78K
Shares Held After
304
% of Holdings
85.1%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
2,268
Price
$117.56
Total Value
$266.63K
Shares Held After
2,034
% of Holdings
52.7%
Neuronetics, Inc. (STIM)
Chernett Jorey — 10% Owner
Shares
607,400
Price
$1.35
Total Value
$819.99K
Shares Held After
8,123,804
% of Holdings
7.5%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
2,651
Price
$53.64
Total Value
$142.21K
Shares Held After
80,360
% of Holdings
3.2%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
3,598
Price
$53.03
Total Value
$190.82K
Shares Held After
83,011
% of Holdings
4.2%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
4,311
Price
$51.80
Total Value
$223.30K
Shares Held After
86,609
% of Holdings
4.7%
ARVINAS, INC. (ARVN)
Berkowitz Noah — Chief Medical Officer
Shares
6,435
Price
$11.10
Total Value
$71.43K
Shares Held After
202,503
% of Holdings
3.1%
Alignment Healthcare, Inc. (ALHC)
JOYCE CHRISTOPHER J — Chief Legal and Admin. Officer
Shares
25,125
Price
$17.84
Total Value
$448.23K
Shares Held After
323,464
% of Holdings
7.2%
Alignment Healthcare, Inc. (ALHC)
Burzacchi Sebastian — COO - Mgmt Services Org
Shares
15,361
Price
$17.84
Total Value
$274.04K
Shares Held After
258,630
% of Holdings
5.6%
Tarsus Pharmaceuticals, Inc. (TARS)
Azamian Bobak R. — Director
Shares
11,667
Price
$68.71
Total Value
$801.64K
Shares Held After
45,385
% of Holdings
20.4%
Alignment Healthcare, Inc. (ALHC)
Kim Hyong — Chief Medical Officer
Shares
18,404
Price
$17.84
Total Value
$328.33K
Shares Held After
367,701
% of Holdings
4.8%
Alignment Healthcare, Inc. (ALHC)
Maroney Dawn Christine — President
Shares
36,749
Price
$17.84
Total Value
$655.60K
Shares Held After
1,058,813
% of Holdings
3.4%
Alignment Healthcare, Inc. (ALHC)
KAO JOHN E — Director
Shares
73,046
Price
$17.84
Total Value
$1.30M
Shares Held After
1,784,868
% of Holdings
3.9%
Phreesia, Inc. (PHR)
Pale Fire Capital SE — 10% Owner
Shares
519,196
Price
$11.15
Total Value
$5.79M
Shares Held After
6,868,820
% of Holdings
7.6%
Tarsus Pharmaceuticals, Inc. (TARS)
Farrow Jeffrey S — Chief Financial Officer and Chief Strategy Officer
Shares
2,133
Price
$68.71
Total Value
$146.56K
Shares Held After
45,502
% of Holdings
4.5%
Tarsus Pharmaceuticals, Inc. (TARS)
Neervannan Seshadri — Chief Operating Officer
Shares
3,610
Price
$68.71
Total Value
$248.04K
Shares Held After
90,369
% of Holdings
3.8%
Tarsus Pharmaceuticals, Inc. (TARS)
Lin Elizabeth Yeu — Chief Medical Officer
Shares
379
Price
$68.71
Total Value
$26.04K
Shares Held After
23,698
% of Holdings
1.6%
Tarsus Pharmaceuticals, Inc. (TARS)
Whitfield Dianne C. — Chief Human Resources Officer
Shares
4,071
Price
$68.71
Total Value
$279.72K
Shares Held After
39,202
% of Holdings
9.4%
Tarsus Pharmaceuticals, Inc. (TARS)
Mottiwala Aziz — Chief Commercial Officer
Shares
4,330
Price
$68.71
Total Value
$297.51K
Shares Held After
65,920
% of Holdings
6.2%
Tarsus Pharmaceuticals, Inc. (TARS)
Wahl Bryan — General Counsel
Shares
4,125
Price
$68.71
Total Value
$283.43K
Shares Held After
68,190
% of Holdings
5.7%
Alignment Healthcare, Inc. (ALHC)
Wagner Andreas P. — Chief Human Resources Officer
Shares
12,000
Price
$17.84
Total Value
$214.08K
Shares Held After
160,230
% of Holdings
7.0%
Alignment Healthcare, Inc. (ALHC)
Scavo Robert L. — Chief Information Officer
Shares
11,285
Price
$17.84
Total Value
$201.32K
Shares Held After
487,685
% of Holdings
2.3%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
72
Price
$32.85
Total Value
$2.37K
Shares Held After
28,836
% of Holdings
0.2%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
334
Price
$31.79
Total Value
$10.62K
Shares Held After
28,908
% of Holdings
1.1%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL & CORP SEC
Shares
4,222
Price
$31.28
Total Value
$132.08K
Shares Held After
29,242
% of Holdings
12.6%
Stoke Therapeutics, Inc. (STOK)
Hoitt Jason — Chief Patient Officer
Shares
30
Price
$32.85
Total Value
$985.50
Shares Held After
10,276
% of Holdings
0.3%
Stoke Therapeutics, Inc. (STOK)
Hoitt Jason — Chief Patient Officer
Shares
139
Price
$31.79
Total Value
$4.42K
Shares Held After
10,306
% of Holdings
1.3%
Stoke Therapeutics, Inc. (STOK)
Hoitt Jason — Chief Patient Officer
Shares
1,762
Price
$31.28
Total Value
$55.12K
Shares Held After
10,445
% of Holdings
14.4%
Stoke Therapeutics, Inc. (STOK)
Leggett Thomas — Chief Financial Officer
Shares
37
Price
$32.85
Total Value
$1.22K
Shares Held After
10,172
% of Holdings
0.4%
Stoke Therapeutics, Inc. (STOK)
Leggett Thomas — Chief Financial Officer
Shares
172
Price
$31.79
Total Value
$5.47K
Shares Held After
10,209
% of Holdings
1.7%
Stoke Therapeutics, Inc. (STOK)
Leggett Thomas — Chief Financial Officer
Shares
2,173
Price
$31.28
Total Value
$67.98K
Shares Held After
10,381
% of Holdings
17.3%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
103
Price
$32.85
Total Value
$3.38K
Shares Held After
40,798
% of Holdings
0.3%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
483
Price
$31.79
Total Value
$15.35K
Shares Held After
40,901
% of Holdings
1.2%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
6,100
Price
$31.28
Total Value
$190.83K
Shares Held After
41,384
% of Holdings
12.8%
Aldeyra Therapeutics, Inc. (ALDX)
Alfieri Michael — Principal Financial Officer
Shares
5,000
Price
$1.42
Total Value
$7.10K
Shares Held After
7,500
% of Holdings
66.7%
Guardant Health, Inc. (GH)
Tariq Musa — Director
Shares
348
Price
$88.09
Total Value
$30.66K
Shares Held After
8,394
% of Holdings
4.0%
Phreesia, Inc. (PHR)
Linetsky David — President, Network Solutions
Shares
107
Price
$11.06
Total Value
$1.18K
Shares Held After
11,068
% of Holdings
1.0%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
650
Price
$25.39
Total Value
$16.50K
Shares Held After
21,479
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$539.99
Total Value
$86.40K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$537.66
Total Value
$21.51K
Shares Held After
40,673
% of Holdings
0.1%
Showing 101–150 of 1861 transactions (page 3 of 38)